Efficace Pharmaceuticals Private Limited
About Efficace Pharmaceuticals Private Limited
Data last updated:
Efficace Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 17 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC299856. Its GSTIN is 07AAECE9164G1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepankar Kakkar and Surendra Kumar Kakkar.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Second Floor 544A A/2 Acharya Niketan Market Mayur Vihar Phase 1, Delhi, India – 110091.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.17 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹1.68 Lakh (net margin -11.8%) and EBITDA of -₹1.56 Lakh (EBITDA margin -11%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 24% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Efficace Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressSecond Floor 544A A/2 Acharya Niketan Market Mayur Vihar Phase 1, Delhi, India – 110091
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Efficace Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Efficace Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Efficace Pharmaceuticals Private Limited, buy the company report.
Financials of Efficace Pharmaceuticals Private Limited
FY 2025 filings availableEfficace Pharmaceuticals Private Limited reported revenue of ₹14.17 Lakh (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11% | ||||
| Net Profit Margin | -11.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Efficace Pharmaceuticals Private Limited, buy the company report.
Board of directors of Efficace Pharmaceuticals Private Limited
Efficace Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepankar Kakkar | Director | 17 May 2016 | 10 Years 5 Months | Current |
| Surendra Kumar Kakkar | Director | 17 May 2016 | 10 Years 5 Months | Current |
| Priyanka Saxena | Director | 16 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Efficace Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vishrava Pharmaceuticals Private Limited | ₹14.23 Lakh (FY 2022) | 16.0% | Thane, Maharashtra, India | |||
| Cytogen Pharmaceuticals (India) Private Limited | ₹14.23 Lakh (FY 2022) | -16.0% | New Delhi, Delhi, India | |||
| JD Sams Pharmaceuticals Private Limited | ₹14.22 Lakh (FY 2025) | -19.0% | Agra, Uttar Pradesh, India | |||
| Efficace Pharmaceuticals Private Limitedthis company | ₹14.17 Lakh (FY 2025) | -₹1.68 Lakh | -11.8% | -18.0% | Delhi, India | |
| Dinsha Pharmaceuticals Private Limited | ₹14.1 Lakh (FY 2025) | 5.0% | Thane, Maharashtra, India |
To see the full peer comparison of Efficace Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Efficace Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Efficace Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Efficace Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Efficace Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Efficace Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE9164G1ZH | Delhi | Active | 25 Jul 2019 |
To see the full GST registrations and return filing status of Efficace Pharmaceuticals Private Limited, buy the company report.
Recent activity
Efficace Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Priyanka Saxena was appointed as Director on 16 Mar 2018.
Frequently asked questions
Efficace Pharmaceuticals is an active private limited company based in Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 17 May 2016 (10+ years old) and is registered under CIN U74999DL2016PTC299856.
Efficace Pharmaceuticals has 3 current directors:
- Deepankar Kakkar - Director
- Surendra Kumar Kakkar - Director
- Priyanka Saxena - Director
The latest financial statements of Efficace Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Efficace Pharmaceuticals is 07AAECE9164G1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Efficace Pharmaceuticals is U74999DL2016PTC299856. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Efficace Pharmaceuticals was incorporated on 17 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Efficace Pharmaceuticals by revenue are Vishrava Pharmaceuticals Private Limited, Cytogen Pharmaceuticals (India) Private Limited, JD Sams Pharmaceuticals Private Limited, Dinsha Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Priyanka Saxena was appointed as Director on 16 Mar 2018. Deepankar Kakkar was appointed as Director on 17 May 2016. Surendra Kumar Kakkar was appointed as Director on 17 May 2016.
The registered office of Efficace Pharmaceuticals is at Second Floor 544A A2 Acharya Niketan Market Mayur Vihar Phase 1, Delhi, India – 110091.
Efficace Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Efficace Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.